The potential role of heat shock proteins in the treatment of ovarian cancer;A hosokkfehérjék lehetséges szerepe a petefészekrák kezelésében

Orvosi Hetilap

Volumn 152, Issue 3, 2011, Pages 92-95

  Langmár, Zoltán ^a,b   Vleskó, Gábor ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b ZÜlloi út 78 B   (Hungary)

Author keywords

heat shock proteins; ovarian cancer; resistance; treatment

Indexed keywords

HEAT SHOCK PROTEIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CARCINOGENESIS; HUMAN; OVARY CARCINOMA; PROTEIN FUNCTION;

EID: 78651105865     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2011.29024     Document Type: Article

References (33)

1. A petefészek-daganatok ellátása. In: A komplex onkodiagnosztika és onkoterápia irányelvei. Szerk.: Kásler M. Semmelweis Kiadó, Budapest, 2008, 421, 424-427.
2. Landriscina, M., Amoroso, R., Piscazzi, A. és mtsai: Heat shock proteins, cell survival and drug resistance: The mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. Gynecol. Oncol., 2010, 117, 177-182.
3. Cohen, M., Dromard, M., Petignat, P.: Heat shock proteins in ovarian cancer: A potential target for therapy. Gynecol. Oncol., 2010, 119, 164-166.
4. Craig, E. A.: Chaperones: Helpers along the pathways to protein folding. Science, 1993, 260, 1902-1903.
5. Hartl, F. U.: Molecular chaperones in cellular protein folding. Nature, 1996, 381, 571-579.
6. Samali, A., Cai, J., Zhivotovsky, B. és mtsai: Presence of a preapoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of Jurkat cells. EMBO J., 1999, 18, 2040-2048.
7. Zylicz, M., King, F. W., Wawrzynow, A.: Hsp70 interactions with the p53 tumour suppressor protein. EMBO J., 2001, 20, 4634-4638.
8. Jäättelä, M., Wissing, D., Kokholm, K. és mtsai: Hsp70 exerts its antiapoptotic function downstream of caspase-3-like proteases. EMBO J., 1998, 17, 6124-6134.
9. Samali, A., Orrenius, S.: Heat shock proteins: Regulators of stress response and apoptosis. Cell Stress Chaperones, 1998, 3, 228-236.
10. Molvarec, A., Derzsy, Z., Kocsis, J. és mtsai: Circulating anti-heatshock- protein antibodies in normal pregnancy and preeclampsia. Cell Stress Chaperones, 2009, 14, 491-498.
11. Kocsis, J., Veres, A., Vatay, A. és mtsai: Antibodies against the human heat shock protein hsp70 in patients with severe coronary artery disease. Immunol. Invest., 2002, 31, 219-231.
12. Papp, D., Prohászka, Z., Kocsis, J. és mtsai: Development of a sensitive assay for the measurement of antibodies against heat shock protein binding protein 1 (HspBP1): Increased levels of anti-HspBP1 IgG are prevalent in HIV infected subjects. J. Med. Virol., 2005, 76, 464-469.
13. Füst, G., Beck, Z., Bánhegyi, D. és mtsai: Antibodies against heat shock proteins and cholesterol in HIV infection. Mol. Immunol., 2005, 42, 79-85.
14. Kocsis, J., Prohászka, Z., Bíró, A. és mtsai: Elevated levels of antibodies against 70 kDa heat shock proteins in the sera of patients with HIV infection. J. Med. Virol., 2003, 71, 480-482.
15. Tang, D., Khaleque, M. A., Jones, E. L. és mtsai: Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones, 2005, 10, 46-58.
16. Ciocca, D. R., Calderwood, S. K.: Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones, 2005, 10, 86-103.
17. Cappello, F., Bellafiore, M., David, S. és mtsai: Ten kilodalton heat shock protein (HSP10) is overexpressed during carcinogenesis of large bowel and uterine exocervix. Cancer Lett., 2003, 196, 35-41.
18. Kocsis, J., Mészáros, T., Madaras, B. és mtsai: High levels of acute phase proteins and soluble 70 kDa heat shock proteins are independent and additive risk factors for mortality in colorectal cancer. Cell Stress Chaperones, 2010 Aug 22. [Epub ahead of print] PubMed PMID:20730518.
19. Kocsis, J., Madaras, B., Tóth, E. K. és mtsai: Serum level of soluble 70-kD heat shock protein is associated with high mortality in patients with colorectal cancer without distant metastasis. Cell Stress Chaperones, 2010, 15, 143-151.
20. Kimura, E., Enns, R. E., Alcaraz, J. E. és mtsai: Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60. J. Clin. Oncol., 1993, 11, 891-898.
21. Schneider, J., Jimenez, E., Marenbach, K. és mtsai: Immunohistochemical detection of HSP60-expression in human ovarian cancer. Correlation with survival in a series of 247 patients. Anticancer Res., 1999, 19, 2141-2146.
22. Arts, H. J., Hollema, H., Lemstra, W. és mtsai: Heat-shock-protein- 27 (hsp27) expression in ovarian carcinoma: Relation in response to chemotherapy and prognosis. Int. J. Cancer, 1999, 84, 234-238.
23. Elstrand, M. B., Kleinberg, L., Kohn, E. C. és mtsai: Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma. Int. J. Gynecol. Pathol., 2009, 28, 211-221.
24. Geisler, J. P., Geisler, H. E., Tammela, J. és mtsai: Heat shock protein 27: An independent prognostic indicator of survival in patients with epithelial ovarian carcinoma. Gynecol. Oncol., 1998, 69, 14-16.
25. Langdon, S. P., Rabiasz, G. J., Hirst, G. L. és mtsai: Expression of the heat shock protein HSP27 in human ovarian cancer. Clin. Cancer Res., 1995, 1, 1603-1609.
26. Schneider, J., Jimenez, E., Marenbach, K. és mtsai: Co-expression of the MDR1 gene and HSP27 in human ovarian cancer. Anticancer Res., 1998, 18, 2967-2971.
27. Annunziata, C. M., Kleinberg, L., Davidson, B. és mtsai: BAG-4/ SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer. Clin. Cancer Res., 2007, 13, 6585-6592.
28. Conroy, S. E., Sasieni, P. D., Fentiman, I. és mtsai: Autoantibodies to the 90 kDa heat shock protein and poor survival in breast cancer patients. Eur. J. Cancer, 1998, 34, 942-943.
29. Luo, L. Y., Herrera, I., Soosaipillai, A. és mtsai: Identifi cation of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library. Br. J. Cancer, 2002, 87, 339-343.
30. Korneeva, I., Bongiovanni, A. M., Girotra, M. és mtsai: IgA antibodies to the 27-kDa heat-shock protein in the genital tracts of women with gynecologic cancers. Int. J. Cancer, 2000, 87, 824-828.
31. Taylor, D. D., Gercel-Taylor, C., Parker, L. P.: Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol. Oncol., 2009, 115, 112-120.
32. Luborsky, J. L., Barua, A., Shatavi, S. V. és mtsai: Antitumor antibodies in ovarian cancer. Am. J. Reprod. Immunol., 2005, 54, 55-62.
33. Olejek, A., Damasiewicz-Bodzek, A., Bodzek, P. és mtsai: Concentrations of antibodies against heat shock protein 27 in the sera of women with ovarian carcinoma. Int. J. Gynecol. Cancer, 2009, 19, 1516-1520.